A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)

NCT02893618 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Prader-Willi Syndrome

Interventions

DRUG: Diazoxide choline controlled-release tablet

Sponsor

Essentialis, Inc.